Share price changes of select biopharmaceutical companies involved in coronavirus (COVID-19) research from January 20 to February 25, 2020
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Coronavirus: the pharma and medtech response
Pharma - before the pandemic
6
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2023
- Premium Statistic Top global pharmaceutical companies based on pharma revenue 2022
- Premium Statistic Size of the global vaccine market by region 2014-2024
- Premium Statistic Leading pharmaceutical companies by global vaccine revenue 2021
- Basic Statistic Global anti-viral market size 2019 and 2027 forecast
- Premium Statistic Leading pharmaceutical companies by global anti-viral revenue 2017 and 2024
Treatments and vaccines
8
- Basic Statistic Biotechs: duration of COVID-19 response compared to previous health threats 2003-2019
- Premium Statistic Number of registered COVID-19 studies worldwide Apr 2020 - Dec 2022, by region
- Basic Statistic Number of COVID-19 drugs in development worldwide by phase June 2022
- Premium Statistic Top companies by COVID-19 treatment vaccines in development June 2022
- Basic Statistic Number of COVID-19 treatment vaccine trials worldwide by phase June 2022
- Basic Statistic Number of COVID-19 treatment vaccine trials worldwide by type June 2022
- Premium Statistic Select COVID-19 vaccine pricing and funding as of August 2020
- Basic Statistic Gilead Science's remdesivir manufacturing projections 2020
Focus: BioNTech and Moderna
7
- Basic Statistic COVID-19 vaccine comparison Biontech/Pfizer vs Moderna 2020
- Basic Statistic Revenue of BioNTech 2017-2023
- Basic Statistic Operating income of BioNTech 2017-2023
- Basic Statistic Total assets of BioNTech 2017-2023
- Basic Statistic Moderna's revenue 2016-2023
- Basic Statistic R&D expenses of Moderna 2016-2023
- Basic Statistic R&D expenses of Moderna by type 2023
Opinions on COVID-19 vaccines
6
- Basic Statistic U.S. adults who would get a coronavirus vaccine, Jan. 2020 to Jan. 2021
- Basic Statistic U.S. adults who would hypothetically get a coronavirus vaccine as of 2020, by gender
- Basic Statistic U.S. adults who would hypothetically get a coronavirus vaccine October 2020, by age
- Basic Statistic Share of Canadians who would get vaccinated for COVID Jul. 2020 - Mar. 2021
- Premium Statistic Willingness to wait before getting COVID-19 vaccine once available in Italy 2020
- Basic Statistic Brazil: intention to get immunized against COVID-19 2021
Business impact
4
- Basic Statistic Market capitalization change in key COVID-19 firms until end-May 2020
- Basic Statistic Top challenges for pharmaceutical companies during COVID-19 2020
- Basic Statistic Launch disruption on global pharmaceutical market due to coronavirus 2020-2025
- Premium Statistic Covid-19 impact: global pharma specialty excipient demand CAGR 2019-2024
Medtech - before the pandemic
5
- Premium Statistic Total medtech revenue worldwide 2011-2024
- Premium Statistic In-vitro diagnostics market revenue worldwide 2016-2028
- Premium Statistic Global in vitro diagnostics market share by top medtech companies 2017 and 2024
- Basic Statistic Global ventilator market size 2018-2026
- Premium Statistic Global ventilator market size by type 2018-2026
Ventilators and testing
7
- Basic Statistic Number of COVID-19-related EUAs for ventilators developed by company May 2020
- Basic Statistic Respiratory devices with potential being modified to ventilators by company 2020
- Basic Statistic Weekly ventilator production change in U.S. due to COVID-19 until April 2020
- Basic Statistic Cumulative EUAs granted to COVID-19 tests March-November 2020
- Basic Statistic Accuracy figures for selected COVID-19 antibody tests sold in the US 2020
- Basic Statistic Number of COVID-19 tests carried out daily in U.S. March-November2020
- Basic Statistic Rate change of COVID-19 testing in select countries April-November 2020
Further related statistics
10
- Pfizer's ad spending 2006-2023
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- MorphoSys' research & development expenditure 2006-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
Further Content: You might find this interesting as well
Statistics
- Pfizer's ad spending 2006-2023
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- MorphoSys' research & development expenditure 2006-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
Vantage. (February 27, 2020). Share price changes of select biopharmaceutical companies involved in coronavirus (COVID-19) research from January 20 to February 25, 2020 [Graph]. In Statista. Retrieved June 10, 2024, from https://www.statista.com/statistics/1103603/coronavirus-related-share-price-changes-in-biopharma/
Vantage. "Share price changes of select biopharmaceutical companies involved in coronavirus (COVID-19) research from January 20 to February 25, 2020." Chart. February 27, 2020. Statista. Accessed June 10, 2024. https://www.statista.com/statistics/1103603/coronavirus-related-share-price-changes-in-biopharma/
Vantage. (2020). Share price changes of select biopharmaceutical companies involved in coronavirus (COVID-19) research from January 20 to February 25, 2020. Statista. Statista Inc.. Accessed: June 10, 2024. https://www.statista.com/statistics/1103603/coronavirus-related-share-price-changes-in-biopharma/
Vantage. "Share Price Changes of Select Biopharmaceutical Companies Involved in Coronavirus (Covid-19) Research from January 20 to February 25, 2020." Statista, Statista Inc., 27 Feb 2020, https://www.statista.com/statistics/1103603/coronavirus-related-share-price-changes-in-biopharma/
Vantage, Share price changes of select biopharmaceutical companies involved in coronavirus (COVID-19) research from January 20 to February 25, 2020 Statista, https://www.statista.com/statistics/1103603/coronavirus-related-share-price-changes-in-biopharma/ (last visited June 10, 2024)
Share price changes of select biopharmaceutical companies involved in coronavirus (COVID-19) research from January 20 to February 25, 2020 [Graph], Vantage, February 27, 2020. [Online]. Available: https://www.statista.com/statistics/1103603/coronavirus-related-share-price-changes-in-biopharma/